Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

iwCLL 2017 | Are prognostic factors the key to precision medicine in CLL?

William Wierda • 11 Aug 2017
iwCLL 2017
Chronic Lymphocytic Leukemia

William Wierda, MD, PhD from MD Anderson Cancer Center, Houston, TX discusses the value of prognostic markers in chronic lymphocytic leukemia (CLL). Prof. Weirda provides an overview of his presentation on precision medicine in CLL, describing how prognostic factors can be used to manage patients and to help predict clinical outcomes. Prof. Weirda details examples of genetic mutations which can act as prognostic markers and discusses how community physicians can test for these in the clinic. This interview was recorded the International Workshop on Chronic Lymphocytic Leukemia (iwCLL) 2017 held in New York, NY.

More from William Wierda

1:12
Primary analysis of TRANSCEND-CLL-004: liso-cel in R/R CLL
William Wierda • 10 Jun 2023
2:08
Disease characteristics impacting treatment decisions in CLL
William Wierda • 10 Jun 2023
2:20
Genomic evolution and resistance to pirtobrutinib in CLL: insights from the BRUIN study
William Wierda • 10 Jun 2023
1:07
The current status of liso-cel in CLL and updates from the TRANSCEND-CLL-004 trial
William Wierda • 28 Sep 2022

Related Videos

3:02
EUPLAGIA-1: Phase I trial of GLPG5201, a CD19 CAR-T product, in R/R CLL and Richter's transformation
Valentin Ortiz-Maldonado • 16 Apr 2024
3:18
A Phase I study of JBH492, an anti-CCR7 antibody-drug conjugate, in lymphoid malignancies
Pau Abrisqueta • 5 Apr 2024
0:44
Early detection and interception across hematological cancers
Irene Ghobrial • 8 Apr 2024
1:21
Monoclonal B-cell lymphocytosis: a disease to be (or not to be)
Paolo Ghia • 7 Apr 2024
The content of VJHemOnc is intended for healthcare professionals